Clinical Priority Analysis
The correct answer is
option 3: a serum potassium level of
2.8 mEq/L with new onset muscle weakness. This finding represents a life-threatening electrolyte imbalance directly linked to the pharmacological action of the prescribed medication,
hydrochlorothiazide.
Pathophysiology and Pharmacological Rationale
Hydrochlorothiazide is a thiazide diuretic that acts on the distal convoluted tubule of the nephron to inhibit the sodium-chloride cotransporter. While effective for reducing blood pressure, a primary adverse effect is increased potassium wasting. By delivering a higher sodium load to the collecting duct, the sodium-potassium exchange pump is upregulated, leading to significant urinary potassium loss. The systematic review by Kumari et al. confirms that electrolyte disturbances, particularly hypokalemia, are a key safety concern when comparing thiazide diuretics, underscoring the need for vigilant monitoring
[1].
Why This Finding is the Highest Priority
A potassium level of
2.8 mEq/L indicates severe hypokalemia (normal range: 3.5-5.0 mEq/L). The patient's new onset muscle weakness is a direct clinical manifestation of this deficit. At a cellular level, a low extracellular potassium concentration hyperpolarizes the resting membrane potential of excitable cells, including skeletal and cardiac muscle. This makes the cell less excitable, leading to weakness and, more critically, predisposing the myocardium to life-threatening arrhythmias such as premature ventricular contractions, ventricular tachycardia, or torsades de pointes. This represents an immediate threat to the patient’s physiological stability and survival, placing it above the other findings in the hierarchy of prioritization.
Analysis of Alternative Options
-
Option 1: A blood pressure of
90/60 mmHg with a heart rate of
110 bpm indicates hypotension with compensatory tachycardia. While this requires prompt intervention, it is a hemodynamic consequence that is often more readily correctable and may be a secondary sign of the primary problem (fluid and electrolyte imbalance). The immediate cardiac risk from severe hypokalemia takes precedence.
-
Option 2: A decrease in urine output from
200 mL/hr to
50 mL/hr over 4 hours is a critical finding suggesting acute kidney injury or severe volume depletion. This requires urgent assessment, but the immediate risk of a fatal cardiac arrhythmia from a known, severely low potassium level is a more time-sensitive emergency. The concept of volume depletion leading to pre-renal failure is highlighted in case reports where medication-induced dehydration causes acute kidney injury, as seen with other agents that cause volume loss .
-
Option 4: A weight loss of
3 kg in 24 hours is an expected therapeutic effect of diuretic therapy, reflecting fluid loss. While it confirms a significant diuresis that could contribute to electrolyte imbalances, the documented hypokalemia with clinical symptoms is the more critical and actionable finding.
Clinical Decision-Making Integration
In the context of antihypertensive therapy, the evolution of treatment strategies, such as low-dose combination therapies, aims to mitigate dose-dependent adverse effects like the hypokalemia seen with higher doses of thiazides . This case illustrates why such strategies are clinically relevant. The nurse’s priority is to recognize that the combination of a severely abnormal lab value and a new physical symptom signals an immediate danger. The muscle weakness is not just a symptom of potassium loss; it is a warning sign of myocardial instability. The nurse must immediately verify the result, place the patient on a cardiac monitor, and notify the healthcare provider to prepare for urgent potassium replacement, as this finding poses the most immediate risk of a fatal outcome.
References (research sources)
- [1]
Comparative efficacy and safety of chlorthalidone <i>vs</i> hydrochlorothiazide in hypertension management: A systematic review and meta-analysis.Meta-analysis/systematic reviewKumari U, Kaka M, Abbas F, Rai A, Kumari S, Wazir HU, Surani S. (2026) · DOI: 10.4330/wjc.v18.i2.112956